Almitas Capital’s Rallybio RLYB Stock Holding History

Almitas Capital’s Portfolio RLYB Stock Details RLYB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Sell	120,682 -70,524	-37%	-$907K	0.46%	46
2026 Q1	$1.72M	Sell	191,206 -1	-0%	-$7	0.39%	50
2025 Q4	$1.05M	Sell	191,207 -1,134	-0.6%	-$5.84K	0.23%	57
2025 Q3	$768K	Sell	192,341 -34,846	-15%	-$146K	0.18%	51
2025 Q2	$614K	Buy	227,187 +64,614	+40%	+$171K	0.16%	51
2025 Q1	$851K	Buy	162,573 +308	+0.2%	+$1.95K	0.28%	50
2024 Q4	$1.25M	Buy	162,265 +52,836	+48%	+$443K	0.27%	50
2024 Q3	$1.02M	Buy	109,429 +96,819	+768%	+$933K	0.36%	45
2024 Q2	$135K	Buy	+12,610	New	+$171K	0.06%	73

Other funds holding RLYB

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Almitas Capital's RLYB Position: Q2 2026 in Review

Almitas Capital reduced its Rallybio (RLYB) stake by 37% in Q2 2026, selling an estimated $907K and leaving 120,682 shares worth $1.93M. The position accounts for 0.46% of the portfolio, ranked #46.

Almitas Capital first reported a position in RLYB in Q2 2024 and has held it in 9 quarters since. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

Almitas Capital held 120,682 shares of Rallybio worth $1.93M as of Q2 2026.
Almitas Capital sold 70,524 Rallybio shares in Q2 2026, an estimated $907K.
Rallybio made up 0.46% of Almitas Capital's portfolio in Q2 2026, its #46 holding.
Almitas Capital first reported a position in Rallybio in Q2 2024 and has held it in 9 quarters since.
37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Almitas Capital's 13F filing for Q2 2026, filed 17 Aug 2026.